Spots Global Cancer Trial Database for intratumoral injection
Every month we try and update this database with for intratumoral injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors | NCT05205408 | Advanced Solid ... | Oncolytic Virus... | 18 Years - | First Affiliated Hospital Bengbu Medical College | |
| Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 | NCT04144140 | Lymphoma Advanced Solid ... | E7766 | 18 Years - | Eisai Inc. | |
| Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin | NCT04502888 | Cutaneous Squam... Squamous Cell C... | Drug: SL-172154 | 18 Years - | Shattuck Labs, Inc. | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 | NCT04144140 | Lymphoma Advanced Solid ... | E7766 | 18 Years - | Eisai Inc. | |
| RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors | NCT05122572 | Advanced Solid ... | Oncolytic Virus... | 18 Years - | Wuxi People's Hospital | |
| A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors | NCT03954067 | Metastatic Canc... Solid Tumors Advanced Cancer | ASP9801 Pembrolizumab | 18 Years - | Astellas Pharma Inc | |
| A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer | NCT04044950 | Papillomavirus ... Oropharyngeal N... | E7 TCR | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies | NCT03301896 | Solid Tumors | LHC165 PDR001 | 18 Years - | Novartis | |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | NCT04673942 | Solid Tumor, Ad... Cancer Neoplasms Sarcoma Sarcoma,Soft Ti... Chondrosarcoma | AdAPT-001 Checkpoint Inhi... | 18 Years - | EpicentRx, Inc. | |
| Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor | NCT06048367 | Advanced Solid ... Lung Cancer Pancreas Cancer Breast Cancer Thyroid Cancer Colorectal Canc... Cervical Cancer Ovarian Cancer Vulva Cancer | CNSI-Fe(II) 30 ... CNSI-Fe(II) 60 ... CNSI-Fe(II) 90 ... | 18 Years - 75 Years | Sichuan Enray Pharmaceutical Sciences Company | |
| RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors | NCT05122572 | Advanced Solid ... | Oncolytic Virus... | 18 Years - | Wuxi People's Hospital | |
| In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® | NCT02423863 | Melanoma Head and Neck C... Sarcoma Non-Melanoma Sk... | Hiltonol | 18 Years - | Oncovir, Inc. | |
| A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer | NCT04044950 | Papillomavirus ... Oropharyngeal N... | E7 TCR | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors | NCT05136937 | Solid Tumor Advanced Cancer | Oncolytic Virus... | 18 Years - | Wuxi People's Hospital | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors | NCT05351502 | Cancer | Nitric Oxide 25... Nitric Oxide 50... Nitric Oxide 10... Nitric Oxide se... | 18 Years - | Beyond Air Inc. | |
| Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors | NCT04787003 | Neoplasms | oncolytic virus... | 18 Years - 70 Years | North China Petroleum Bureau General Hospital | |
| Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease | NCT04685499 | Head and Neck S... | OBP-301 Pembrolizumab | 18 Years - | Weill Medical College of Cornell University | |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors | NCT05727839 | Cutaneous Tumor Malignant Solid... | JCXH-211 Inject... | 18 Years - 75 Years | Immorna Biotherapeutics, Inc. | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors | NCT05727839 | Cutaneous Tumor Malignant Solid... | JCXH-211 Inject... | 18 Years - 75 Years | Immorna Biotherapeutics, Inc. | |
| Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors | NCT04301011 | Solid Tumor Microsatellite ... HPV Positive Or... Cervical Cancer Melanoma (Skin) Cutaneous Squam... Mesothelioma Renal Cell Carc... Oropharynx Canc... | TBio-6517 Pembrolizumab | 18 Years - | Turnstone Biologics, Corp. | |
| Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor | NCT06048367 | Advanced Solid ... Lung Cancer Pancreas Cancer Breast Cancer Thyroid Cancer Colorectal Canc... Cervical Cancer Ovarian Cancer Vulva Cancer | CNSI-Fe(II) 30 ... CNSI-Fe(II) 60 ... CNSI-Fe(II) 90 ... | 18 Years - 75 Years | Sichuan Enray Pharmaceutical Sciences Company | |
| Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors | NCT04787003 | Neoplasms | oncolytic virus... | 18 Years - 70 Years | North China Petroleum Bureau General Hospital | |
| A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors | NCT05228119 | Advanced Solid ... | Oncolytic Virus... | 18 Years - | The Affiliated Hospital of Xuzhou Medical University | |
| A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors | NCT05205408 | Advanced Solid ... | Oncolytic Virus... | 18 Years - | First Affiliated Hospital Bengbu Medical College | |
| Phase I Study of RiMO-401 With Radiation in Advanced Tumors | NCT06182579 | Advanced Solid ... Intratumoral In... | RiMO-401 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® | NCT02423863 | Melanoma Head and Neck C... Sarcoma Non-Melanoma Sk... | Hiltonol | 18 Years - | Oncovir, Inc. | |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors | NCT05539157 | Cutaneous Tumor Malignant Solid... | JCXH-211 | 18 Years - 75 Years | Immorna Biotherapeutics, Inc. | |
| The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors | NCT06430515 | Intratumoral In... Cancer | Intratumoral In... | 18 Years - 85 Years | Wuxi People's Hospital | |
| Phase I Study of RiMO-401 With Radiation in Advanced Tumors | NCT06182579 | Advanced Solid ... Intratumoral In... | RiMO-401 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Lerapolturev (PVSRIPO) in GBM | NCT06177964 | Recurrent Supra... | Lerapolturev Lomustine Pill | 18 Years - | Duke University | |
| External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | NCT00365872 | Soft Tissue Sar... | Dendritic Cell ... Radiation thera... Complete Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | NCT00365872 | Soft Tissue Sar... | Dendritic Cell ... Radiation thera... Complete Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
